Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07234292

Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery

The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).

The participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Pierre-Vincent Jacomet Private Practice

Paris, France

Location status: Recruiting

Location contact

Pierre-Vincent Jacomet, Dr.

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years old
  • Patients planning a blepharoplasty or a ptosis surgery in at least one eye.
  • Patient affiliated to a health social security system
  • Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.

Exclusion criteria

In terms of population:

  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Patient who had been deprived of their freedom by administrative or legal decision
  • Minor patient.
  • Major patient who is under guardianship or who is not able to express his non opposition.
  • Patient suspected to be non-compliant according to the investigator's judgment.
  • Patient enrolled in another clinical trial or which exclusion period is not over.

In terms of associated pathology

  • Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk.
  • Patient suffering from a severe or progressive disease.
  • Patient with known or suspected hypersensitivity to one of the components of the product.

Related to previous or ongoing treatment

  • Patient undergoing a topical treatment on the test area or a systemic treatment.
  • Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation.
  • Patient under immunosuppressive therapy
  • Patient under bisphosphonate therapy
  • Patient having Type 1 diabetes
  • Patient having atopic or eczema skin

In terms of lifestyle

  • Intensive exposure to sunlight or UV-rays foreseen during the study.
  • Patient planning to change her/his life habits during the study.
  • Patient with an excessive consumption of alcohol and/or tobacco defined as:
  • an excessive consumption of alcohol: Drinking more than
  • 4 units a day for adult men and more than 2 units a day for adult women,
  • an excessive consumption of tobacco: ≥15-20 Cigarettes Per Day (CPD).

Treatment and study plan

Cosmetic: Blephaderm

Other

Preservative free eyelid cream: Aqua (water), oleyl erucate, trehalose, sodium acrylates copolymer, lecithin, Ophiopogon japonicus root extract, hydrolyzed hyaluronic acid, maltodextrin, tocopherol, sodium hydroxide, phytic acid, Glycine soja (soybean) oil, Helianthus annuus seed oil.

Primary outcomes

  1. global satisfaction of the patient on eyelid comfort after 3 months of Bllephaderm® use, assessed at M4, using a VAS from 0 (unsatisfied) to 10 (very satisfied).

    Time frame: 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Medical Affairs Director

CONTACT

[email protected]

+33 4 73 98 14 36

Sponsors and collaborators

Lead sponsor

Laboratoires Thea

Industry

Registry information

Official study title

Evaluation of Patient Satisfaction With a New Preservative-free Eyelid Cream as a Complementary Care in Post-eyelid Surgery: The ADMIRE Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Nov 18, 2025
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.